Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research
暂无分享,去创建一个
[1] Tudor I. Oprea,et al. Target, chemical and bioactivity databases – integration is key , 2006 .
[2] J. Brecher. Name=Struct: A Practical Approach to the Sorry State of Real-Life Chemical Nomenclature , 1999, J. Chem. Inf. Comput. Sci..
[3] Victor Kuzmin,et al. Hierarchical QSAR technology based on the Simplex representation of molecular structure , 2008, J. Comput. Aided Mol. Des..
[4] E. Muratov,et al. Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication. , 2007, Journal of medicinal chemistry.
[5] Alexander Golbraikh,et al. Predictive QSAR modeling workflow, model applicability domains, and virtual screening. , 2007, Current pharmaceutical design.
[6] K. C. Pugh,et al. Toxicity and physical properties of atrazine and its degradation products: A literature survey , 1994 .
[7] Sorel Muresan,et al. Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds , 2009, J. Cheminformatics.
[8] Haruki Nakamura,et al. Data Deposition and Annotation at the Worldwide Protein Data Bank , 2009, Molecular biotechnology.
[9] Roberto Todeschini,et al. Handbook of Molecular Descriptors , 2002 .
[10] Yi Li,et al. In silico ADME/Tox: why models fail , 2003, J. Comput. Aided Mol. Des..
[11] Michiko Amano,et al. Novel Method for the Evaluation of 3D Conformation Generators , 2009, J. Chem. Inf. Model..
[12] Alexander Tropsha,et al. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. , 2010, Chemical research in toxicology.
[13] Alexandre Varnek,et al. Substructural fragments: an universal language to encode reactions, molecular and supramolecular structures , 2005, J. Comput. Aided Mol. Des..
[14] Igor V. Tetko,et al. Combinatorial QSAR Modeling of Chemical Toxicants Tested against Tetrahymena pyriformis , 2008, J. Chem. Inf. Model..
[15] G. Zlokarnik,et al. In silico prediction of drug safety: despite progress there is abundant room for improvement. , 2004, Drug discovery today. Technologies.
[16] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[17] J. Dearden,et al. How not to develop a quantitative structure–activity or structure–property relationship (QSAR/QSPR) , 2009, SAR and QSAR in environmental research.
[18] William L. Jorgensen,et al. QSAR/QSPR and Proprietary Data , 2006, Journal of Chemical Information and Modeling.
[19] A Tropsha,et al. QSAR analysis of the toxicity of nitroaromatics in Tetrahymena pyriformis: structural factors and possible modes of action , 2011, SAR and QSAR in environmental research.
[20] Emilio Xavier Esposito,et al. Findings of the Challenge To Predict Aqueous Solubility , 2009, J. Chem. Inf. Model..
[21] Arthur M. Doweyko,et al. QSAR: dead or alive? , 2008, J. Comput. Aided Mol. Des..
[22] M. Boyd,et al. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. , 1989, Journal of the National Cancer Institute.
[23] Klaus-Robert Müller,et al. Benchmark Data Set for in Silico Prediction of Ames Mutagenicity , 2009, J. Chem. Inf. Model..
[24] Bert van Bavel,et al. European "REACH" (Registration, Evaluation, Authorisation and Restriction of Chemicals) program. , 2009 .
[25] K. Hornbuckle,et al. Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999 , 2001 .
[26] Stephen R. Johnson,et al. The Trouble with QSAR (or How I Learned To Stop Worrying and Embrace Fallacy) , 2008, J. Chem. Inf. Model..
[27] David M. Reif,et al. Profiling Chemicals Based on Chronic Toxicity Results from the U.S. EPA ToxRef Database , 2008, Environmental health perspectives.
[28] P. Bernardi,et al. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening , 2006, Archives of Toxicology.
[29] G. Betton,et al. The predictivity of the toxicity of pharmaceuticals in humans from animal data--an interim assessment. , 1998, Toxicology letters.
[30] Paul B Watkins,et al. Drug‐induced liver injury: Summary of a single topic clinical research conference , 2006, Hepatology.
[31] H. Kubinyi,et al. Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices. , 1998, Journal of medicinal chemistry.
[32] Yvonne C. Martin,et al. Let’s not forget tautomers , 2009, J. Comput. Aided Mol. Des..
[33] Michal Vieth,et al. Geometric Accuracy of Three-Dimensional Molecular Overlays , 2006, J. Chem. Inf. Model..
[34] J. Leszczynski,et al. The effect of nitroaromatics' composition on their toxicity in vivo: novel, efficient non-additive 1D QSAR analysis. , 2008, Chemosphere.
[35] Damian Szklarczyk,et al. STITCH 2: an interaction network database for small molecules and proteins , 2009, Nucleic Acids Res..
[36] A. Tropsha,et al. Beware of q 2 , 2002 .
[37] Tudor I. Oprea,et al. WOMBAT and WOMBAT‐PK: Bioactivity Databases for Lead and Drug Discovery , 2008 .
[38] Jerzy Leszczynski,et al. Consensus QSAR Modeling of Phosphor‐Containing Chiral AChE Inhibitors , 2009 .
[39] Robert C. Glen,et al. Solubility Challenge: Can You Predict Solubilities of 32 Molecules Using a Database of 100 Reliable Measurements? , 2008, J. Chem. Inf. Model..
[40] Tingjun Hou,et al. ADME Evaluation in Drug Discovery, 6. Can Oral Bioavailability in Humans Be Effectively Predicted by Simple Molecular Property-Based Rules? , 2007, J. Chem. Inf. Model..
[41] Igor V. Tetko,et al. Critical Assessment of QSAR Models of Environmental Toxicity against Tetrahymena pyriformis: Focusing on Applicability Domain and Overfitting by Variable Selection , 2008, J. Chem. Inf. Model..
[42] Ivonne M C M Rietjens,et al. Promises and pitfalls of quantitative structure-activity relationship approaches for predicting metabolism and toxicity. , 2008, Chemical research in toxicology.
[43] P Smith,et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.
[44] Antony J. Williams,et al. Free online resources enabling crowd-sourced drug discovery , 2009 .
[45] T. Insel,et al. NIH Molecular Libraries Initiative , 2004, Science.
[46] Gerald M. Maggiora,et al. On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..
[47] Jerzy Leszczynski,et al. The effects of characteristics of substituents on toxicity of the nitroaromatics: HiT QSAR study , 2008, J. Comput. Aided Mol. Des..
[48] D. Young,et al. Are the Chemical Structures in Your QSAR Correct , 2008 .
[49] Tudor I. Oprea,et al. WOMBAT: World of Molecular Bioactivity , 2005 .
[50] John M. Barnard,et al. Clustering Methods and Their Uses in Computational Chemistry , 2003 .